PATRICIA CARMEN
MUÑOZ GARCÍA
Catedrática de universidad
Necker-Enfants Malades Hospital
París, FranciaPublicaciones en colaboración con investigadores/as de Necker-Enfants Malades Hospital (14)
2023
-
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae
American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034
2021
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases, Vol. 21, Núm. 12, pp. e375-e386
-
Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11
2020
-
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey
Mycoses, Vol. 63, Núm. 5, pp. 420-429
2015
-
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey
Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9
2014
-
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 27-46
2010
-
Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis
Transplantation, Vol. 89, Núm. 1, pp. 69-74
-
Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients
Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069
2009
-
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728
2008
-
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis
Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738
-
Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings
Transplantation, Vol. 86, Núm. 5, pp. 647-651
-
Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen
Clinical Infectious Diseases, Vol. 46, Núm. 2
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Clinical Infectious Diseases, Vol. 46, Núm. 12, pp. 1813-1821
2007
-
Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality
Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764